Found: 20
Select item for more details and to access through your institution.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 503, doi. 10.1002/ajh.25758
- By:
- Publication type:
- Article
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 575, doi. 10.1002/ajh.24351
- By:
- Publication type:
- Article
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 411, doi. 10.3390/cells10020411
- By:
- Publication type:
- Article
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 494, doi. 10.1111/ejh.13231
- By:
- Publication type:
- Article
The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a “real‐world” study: Polish Myeloma Group experience.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 3, p. 354, doi. 10.1111/ejh.13106
- By:
- Publication type:
- Article
<sup>18</sup>F-fluoro-ethyl-tyrosine (<sup>18</sup>F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2019, v. 23, n. 1, p. 23, doi. 10.5114/wo.2019.83342
- By:
- Publication type:
- Article
Acute T Cell Lymphoblastic Leukemia in the Recipient of a Renal Transplant from a Donor with Malignant Lymphoma.
- Published in:
- Acta Haematologica, 2008, v. 119, n. 3, p. 187, doi. 10.1159/000137944
- By:
- Publication type:
- Article
An Open-label, Phase 2 Study to Evaluate the Oral Combination of Ixazomib, Cyclophosphamide, and Dexamethasone (ICd) in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S333, doi. 10.1016/j.clml.2017.07.148
- By:
- Publication type:
- Article
Phase 2 Study of the All-Oral Combination of Ixazomib Plus Cyclophosphamide and Low-Dose Dexamethasone (ICd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e131, doi. 10.1016/j.clml.2017.03.237
- By:
- Publication type:
- Article
Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 4, p. 325, doi. 10.1007/s00228-006-0106-2
- By:
- Publication type:
- Article
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 5811, doi. 10.3892/ol.2019.10929
- By:
- Publication type:
- Article
Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 536, doi. 10.1111/bjh.15679
- By:
- Publication type:
- Article
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 6, p. 831, doi. 10.1111/bjh.15092
- By:
- Publication type:
- Article
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 783, doi. 10.1111/bjh.14483
- By:
- Publication type:
- Article
Therapy-related peripheral neuropathy in multiple myeloma patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 1, p. 41, doi. 10.1002/hon.2018
- By:
- Publication type:
- Article
A Stepwise Screening Protocol for Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1345, doi. 10.3390/jcm12041345
- By:
- Publication type:
- Article
Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5504, doi. 10.3390/jcm10235504
- By:
- Publication type:
- Article
Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 8, p. 1887, doi. 10.1002/ijc.33377
- By:
- Publication type:
- Article
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article